Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy

American Journal of Ophthalmology

Volumn 133, Issue 1, 2002, Pages 48-61

  Jabs, Douglas A ^a   Van Natta, Mark L ^a   Kempen, John H ^a   Pavan, Peter Reed ^a   Lim, Jennifer I ^a   Murphy, Robert L ^a   Hubbard, Larry D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CIDOFOVIR; FOSCARNET; GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CONVALESCENCE; CYTOMEGALOVIRUS; EPIDEMIC; FEMALE; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; INCIDENCE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEGRO; PREVALENCE; PRIORITY JOURNAL; RETINITIS; SEX DIFFERENCE; T LYMPHOCYTE; UVEITIS;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; CYTOMEGALOVIRUS RETINITIS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; UNITED STATES; UVEITIS;

EID: 0036148962     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(01)01322-8     Document Type: Article

References (38)

1. Ocular manifestations of HIV infection
2. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine
3. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus
4. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression
5. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
6. Restoration of cytomegalovirus-specific CD4 + T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1
7. AIDS and ophthalmology: A period of transition
8. Decline in the rate of specific opportunistic infections at San Francisco General Hospital
9. Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy
10. Discontinuing anti-CMV therapy in patients with immune reconstitution after combination antiretroviral therapy
11. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients
12. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T-cells in response to highly active antiretroviral therapy
13. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis
14. CMV retinitis recurs after stopping treatment in virological and immunological failure of potent antiretroviral therapy
15. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis
16. Immune recovery vitritis associated with inactive CMV retinitis: A new syndrome
17. Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy
18. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis following highly active antiretroviral therapy
19. Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy
20. Long-term posterior and anterior segment complications of immune recovery uveitis associated with cytomegalovirus retinitis
21. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
22. New visual acuity charts for clinical research
23. Foscarnet-ganciclovir cytomegalovirus retinitis trial 1. Rationale, design and methods
24. Photocoagulation treatment of proliferative diabetic retinopathy: The second report of diabetic retinopathy study findings
25. Foscarnet-ganciclovir cytomegalovirus retinitis trial: 4. Visual outcomes
26. Combination foscarnet and ganciclovir therapy versus monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS
27. MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome
28. The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with AIDS: The ganciclovir cidofovir retinitis trial
29. Comparison of cytomegalovirus loads in plasma and leukocytes of patients with cytomegalovirus retinitis
30. Longitudinal data analysis using generalized estimating linear models
31. Foscarnet-ganciclovir cytomegalovirus retinitis trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis
32. An overview of the global HIV/AIDS epidemic, with a focus on the United States
33. CD8 + T lymphocytes and cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome
34. T-cell subsets and cytomegalovirus retinitis in human immunodeficiency virus-infected patients
35. Correlation between CD4 + counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome
36. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy